-
The 15 billion contrast agent market welcomes new players again!
Time of Update: 2021-12-28
com, in 2020, the sales of terminal contrast agents in public medical institutions in China will exceed 15 billion yuan, with a year-on-year growth of more than 25% in 2021H1 .
-
One shot of 700,000 changed to 30,000, how did the "sky price" be "cut down"?
Time of Update: 2021-12-28
However, Nossinassen Sodium, which has the largest clinical research data in the SMA field, was not included in the National Medical Insurance Drug List that year due to various factors such as excessive prices .
-
A reporter asked why the negotiations on medical insurance drugs did not directly show low prices?
Time of Update: 2021-12-28
On the one hand, for drugs that are eligible for negotiation, the medical insurance department organizes relevant companies to submit calculation data according to a unified template, which mainly includes: basic drug information, relevant safety, effectiveness, and economic information, intended prices, and corresponding evidence materials .
-
Yangtze River won two major injections!
Time of Update: 2021-12-28
Before 2018, Hengrui was a leader in dexmedetomidine hydrochloride injection, with a market share of more than 80%; at the end of 2018, the 4+7 pilot project opened the prelude to the collection, and Yangtze River was deemed to have passed the review according to the new classification.
-
Internet diagnosis and treatment supervision rules open for public comments to "open gates" for online prescription drugs to strengthen safety dams
Time of Update: 2021-12-28
"The "Draft for Comments" proposes that medical institutions should establish a pharmaceutical service system, which has a positive effect on the development of online prescription drug dispensing business .
-
The results of the selection of 45 medicines in the 13 provinces alliance of Guangdong are released
Time of Update: 2021-12-28
The results of the centralized procurement of 45 varieties of the Guangdong 13-province alliance were announced, involving 313 product specifications and 130 pharmaceutical companies .
-
Sichuan Creed, the only short-acting muscle relaxant in China, won the first imitation!
Time of Update: 2021-12-28
According to data from Meinenet, in 2020, the sales volume of terminal muscle relaxants in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will exceed 4 billion yuan .
. Figure 1: Sales of terminal muscle relaxants in China's public medical institutions (unit: 10,000 yuan) Source: Mi Nei. com.
-
No one should be given up!
Time of Update: 2021-12-28
When Zhang Jinni, the negotiator of the National Medical Insurance Agency in the video, said the word "deal", almost all parents of children with spinal muscular atrophy (SMA) cried .
-
Guangxi: Establish and improve the "dual-channel" management mechanism for drugs in national medical insurance negotiations
Time of Update: 2021-12-28
The "Notice" stated that "dual-channel" medical institutions are encouraged to provide "Internet +" drug circulation services, standardize Internet sales services, and achieve "online ordering store pickup" or "online ordering store delivery" .
-
1,410 medical institutions in Beijing realize direct settlement of outpatient fees across provinces
Time of Update: 2021-12-28
According to the relevant person in charge of the Municipal Medical Insurance Bureau, as of the end of September, 1410 designated medical institutions in this city have achieved direct settlement of outpatient consultations in different places across provinces, of which 242 designated medical institutions above secondary level have all opened off-site settlement services .
-
Pharmacy services in pharmacies began to be graded primary, basic, and advanced
Time of Update: 2021-12-27
2. Health protection function: patient-centered, drug treatment management is the core content, and professional pharmacy services are provided .
In addition, the document divides the professional services provided by social pharmacies into three levels: primary pharmacy, basic pharmacy, and advanced pharmacy .
-
Each of the 26 major events in primary care in 2021 is related to you
Time of Update: 2021-12-27
On April 6, the General Office of the National Health Commission and other six departments jointly issued the "Notice on Carrying out Special Control Actions for Irrational Medical Examinations" for all medical institutions for a one-year period.
-
Why is a 9-valent HPV vaccine hard to find?
Time of Update: 2021-12-27
Qiao Youlin said that at present, the reason why the HPV vaccine is difficult to obtain is the imbalance between supply and demand .
In 2017, Merck’s quadrivalent HPV vaccine was also approved for domestic marketing after 8 years of clinical trials .
-
Recovered more than 12 million!
Time of Update: 2021-12-27
In accordance with the "Social Insurance Law of the People's Republic of China" and the "Medicine Service Agreement of Jinan Basic Medical Insurance Designated Medical Institutions", the medical insurance department recovered 155,500 yuan of illegal expenses, ordered the hospital to return the defrauded medical insurance fund of 9,873 yuan, and imposed an administrative penalty of 29,619 yuan.
-
Baekje broke 16% on the first day, and WuXi AppTec and others suffered Waterloo!
Time of Update: 2021-12-27
As a star enterprise of local pharmaceutical innovation, BeiGene has been equipped with multiple auras since its establishment in 2010: business genius Ou Leiqiang and scientific top performer Wang Xiaodong are the co-founders of the company, and then dig Come to Pfizer China "Godfather" Wu Xiaobin as president; "Seven years of grinding a sword" BTK small molecule inhibitor Zebutinib is China's first domestic research and development antibody approved for breakthrough therapy by the U.
-
20 gynecological Chinese patent medicine into pharmacies sweet and pastry!
Time of Update: 2021-12-27
2021E key city entity pharmacy gynecological Chinese patent medicine brand TOP20 Source: Meinenet key city entity pharmacy terminal competition pattern of TOP20 brands, Shanxi Guangyuyuan Sinopharm's Dingkundan, Sichuan Enwei Pharmaceutical's Jieryin Lotion, Hainan Bikai Medicine Baofukang Suppository of the industry ranks in the top three; from the perspective of the number of brands, Zhuzhou Qianjin Pharmaceutical has the most, with 4, adding Jiawei Xiaoyao Pills compared with last year .
-
700 million cardiovascular injections!
Time of Update: 2021-12-27
According to data from Meinenet, in 2020, the sales of nicorandil for terminal injection in China's public medical institutions exceeded the 700 million yuan mark, an increase of more than 50% year-on-year in the first half of this year, and the only manufacturer was Beijing Sihuan Kebao Pharmaceutical .
-
1 billion large varieties!
Time of Update: 2021-12-27
178 billion yuan in the Chinese market in 2020 .
In the Chinese market, lenvatinib sales rose from 189 million yuan in 2018 to 1.
Eisai lenvatinib sales in China (unit: million yuan) Source: Mynet.
com's multinational listed company sales database.
-
Outpatient expenses are directly settled across provinces and enter the "fast lane"
Time of Update: 2021-12-27
According to the National Medical Security Administration, as of now, the direct settlement of hospitalization expenses for medical treatment in different places across provinces has covered the whole country.
-
The Tibet Autonomous Region Medical Insurance Bureau notified the national centralized procurement of drugs and procurement related issues
Time of Update: 2021-12-27
The details are as follows: All relevant regional (city) medical security bureaus: Since the national organization of centralized drug procurement, individual medical institutions in our district have severely decoupled from reporting and procurement, and there is even the problem of zero completion ratio of agreed procurement, which seriously affects our country.
